世界の分子診断市場2021年ｰ2028年：技術別（PCR＆リアルタイムPCR、ハイブリダイゼーション、マイクロアレイ、TMA、次世代シーケンシング、その他）、用途別、エンドユーザー別

• 英文タイトル：Molecular Diagnostics Market (Technology: PCR & Real-time PCR, Hybridization, Microarray, Transcription-mediated Amplification, Next Generation Sequencing, and Others; Application: Infectious Diseases [Virology and Bacteriology], Oncology, Blood Screening, Microbiology, Genetic Testing, and Women’s Health; and End-user: Hospitals, Diagnostics Laboratories, Blood Banks, Academics & Research, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

• レポートコード：MRC2205A016 • 出版社/出版日：Transparency Market Research / 2022年3月14日 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥857,660 (USD5,795)	▷ お問い合わせ
Multi User	￥1,301,660 (USD8,795)	▷ お問い合わせ
Corporate License	￥1,745,660 (USD11,795)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

Transparency Market Research社の本調査レポートは、世界の分子診断市場について調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、技術別（PCR＆リアルタイムPCR、ハイブリダイゼーション、マイクロアレイ、TMA、次世代シーケンシング）分析、用途別分析、エンドユーザー別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などの項目を掲載しています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・世界の分子診断市場規模：技術別（PCR＆リアルタイムPCR、ハイブリダイゼーション、マイクロアレイ、TMA、次世代シーケンシング） ・世界の分子診断市場規模：用途別 ・世界の分子診断市場規模：エンドユーザー別 ・世界の分子診断市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況

Molecular Diagnostics Market – Scope of Report

TMR’s report on the global molecular diagnostics market studies past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global molecular diagnostics market for the period 2017–2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global molecular diagnostics market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global molecular diagnostics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global molecular diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global molecular diagnostics market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global molecular diagnostics market.

The report delves into the competition landscape of the global molecular diagnostics market. Key players operating in the global molecular diagnostics market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global molecular diagnostics market that have been profiled in this report.

Key Questions Answered in Global Molecular Diagnostics Market Report
What is the scope of growth of companies in the global molecular diagnostics market?
What will be the Y-o-Y growth of the global molecular diagnostics market between 2021 and 2028?
What is the influence of changing trends in technologies on the global molecular diagnostics market?
Will North America be the most profitable market for molecular diagnostics devices providers?
Which factors are anticipated to hamper the growth of the global molecular diagnostics market during the forecast period?
Which are the leading companies in the global molecular diagnostics market?

Research Methodology
A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global molecular diagnostics market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the molecular diagnostics market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the molecular diagnostics market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the molecular diagnostics market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global molecular diagnostics market with accuracy. The study also uses the top-down approach to assess the revenue for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global molecular diagnostics market more reliably and accurately.

レポート目次

---

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Molecular Diagnostics Market
4. Market Overview
4.1. Introduction
4.1.1. End-user Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Molecular Diagnostics Market Analysis and Forecast, 2017–2028
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Future Market Outlook
5.2. Key Industry Events
5.3. Porter’s Five Force Analysis
5.4. COVID-19 Pandemics Impact on Industry (value chain and short / mid / long term impact)
6. Global Molecular Diagnostics Market Analysis and Forecast, by End-user
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by End-user, 2017–2028
6.3.1. PCR & Real-time PCR
6.3.2. Hybridization
6.3.3. Microarray
6.3.4. Transcription-mediated Amplification
6.3.5. Next-Generation Sequencing
6.3.6. Others
6.4. Market Attractiveness Analysis, by End-user
7. Global Molecular Diagnostics Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2028
7.3.1. Infectious Diseases
7.3.1.1. Virology
7.3.1.2. Bacteriology
7.3.2. Oncology
7.3.3. Blood Screening
7.3.4. Microbiology
7.3.5. Genetic Testing
7.3.6. Women’s Health
7.4. Market Attractiveness Analysis, by Application
8. Global Molecular Diagnostics Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2028
8.3.1. Hospitals
8.3.2. Diagnostics Laboratories
8.3.3. Blood Banks
8.3.4. Academics & Research
8.3.5. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Molecular Diagnostics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Molecular Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by End-user, 2017–2028
10.2.1. PCR & Real-time PCR
10.2.2. Hybridization
10.2.3. Microarray
10.2.4. Transcription-mediated Amplification
10.2.5. Next-Generation Sequencing
10.2.6. Others
10.3. Market Value Forecast, by Application, 2017–2028
10.3.1. Infectious Diseases
10.3.1.1. Virology
10.3.1.2. Bacteriology
10.3.2. Oncology
10.3.3. Blood Screening
10.3.4. Microbiology
10.3.5. Genetic Testing
10.3.6. Women’s Health
10.4. Market Value Forecast, by End-user, 2017–2028
10.4.1. Hospitals
10.4.2. Diagnostics Laboratories
10.4.3. Blood Banks
10.4.4. Academics & Research
10.4.5. Others
10.5. Market Value Forecast, by Country, 2017–2028
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By End-user
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Molecular Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by End-user, 2017–2028
11.2.1. PCR & Real-time PCR
11.2.2. Hybridization
11.2.3. Microarray
11.2.4. Transcription-mediated Amplification
11.2.5. Next-Generation Sequencing
11.2.6. Others
11.3. Market Value Forecast, by Application, 2017–2028
11.3.1. Infectious Diseases
11.3.1.1. Virology
11.3.1.2. Bacteriology
11.3.2. Oncology
11.3.3. Blood Screening
11.3.4. Microbiology
11.3.5. Genetic Testing
11.3.6. Women’s Health
11.4. Market Value Forecast, by End-user, 2017–2028
11.4.1. Hospitals
11.4.2. Diagnostics Laboratories
11.4.3. Blood Banks
11.4.4. Academics & Research
11.4.5. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2028
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By End-user
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Molecular Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by End-user, 2017–2028
12.2.1. PCR & Real-time PCR
12.2.2. Hybridization
12.2.3. Microarray
12.2.4. Transcription-mediated Amplification
12.2.5. Next-Generation Sequencing
12.2.6. Others
12.3. Market Value Forecast, by Application, 2017–2028
12.3.1. Infectious Diseases
12.3.1.1. Virology
12.3.1.2. Bacteriology
12.3.2. Oncology
12.3.3. Blood Screening
12.3.4. Microbiology
12.3.5. Genetic Testing
12.3.6. Women’s Health
12.4. Market Value Forecast, by End-user, 2017–2028
12.4.1. Hospitals
12.4.2. Diagnostics Laboratories
12.4.3. Blood Banks
12.4.4. Academics & Research
12.4.5. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2028
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By End-user
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Molecular Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by End-user, 2017–2028
13.2.1. PCR & Real-time PCR
13.2.2. Hybridization
13.2.3. Microarray
13.2.4. Transcription-mediated Amplification
13.2.5. Next-Generation Sequencing
13.2.6. Others
13.3. Market Value Forecast, by Application, 2017–2028
13.3.1. Infectious Diseases
13.3.1.1. Virology
13.3.1.2. Bacteriology
13.3.2. Oncology
13.3.3. Blood Screening
13.3.4. Microbiology
13.3.5. Genetic Testing
13.3.6. Women’s Health
13.4. Market Value Forecast, by End-user, 2017–2028
13.4.1. Hospitals
13.4.2. Diagnostics Laboratories
13.4.3. Blood Banks
13.4.4. Academics & Research
13.4.5. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2028
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By End-user
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Molecular Diagnostics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by End-user, 2017–2028
14.2.1. PCR & Real-time PCR
14.2.2. Hybridization
14.2.3. Microarray
14.2.4. Transcription-mediated Amplification
14.2.5. Next-Generation Sequencing
14.2.6. Others
14.3. Market Value Forecast, by Application, 2017–2028
14.3.1. Infectious Diseases
14.3.1.1. Virology
14.3.1.2. Bacteriology
14.3.2. Oncology
14.3.3. Blood Screening
14.3.4. Microbiology
14.3.5. Genetic Testing
14.3.6. Women’s Health
14.4. Market Value Forecast, by End-user, 2017–2028
14.4.1. Hospitals
14.4.2. Diagnostics Laboratories
14.4.3. Blood Banks
14.4.4. Academics & Research
14.4.5. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2028
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By End-user
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2020
15.3. Company Profiles
15.3.1. Abbott Laboratories
15.3.1.1. Company Overview
15.3.1.2. Business Overview
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Becton, Dickinson and Company
15.3.2.1. Company Overview
15.3.2.2. Business Overview
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Bio-Rad Laboratories, Inc.
15.3.3.1. Company Overview
15.3.3.2. Business Overview
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. BioMérieux SA
15.3.4.1. Company Overview
15.3.4.2. Business Overview
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Danaher Corporation
15.3.5.1. Company Overview
15.3.5.2. Business Overview
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. F. Hoffmann-La Roche Ltd.
15.3.6.1. Company Overview
15.3.6.2. Business Overview
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. QIAGEN N.V.
15.3.7.1. Company Overview
15.3.7.2. Business Overview
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Siemens AG
15.3.8.1. Company Overview
15.3.8.2. Business Overview
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Thermo Fisher Scientific Inc.
15.3.9.1. Company Overview
15.3.9.2. Business Overview
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview

---